Latest Content
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
Beacon Immune Tolerance: 2024 EULAR Annual Meeting Abstracts
Unlock the Future of Advanced Therapies: Insights from the ASGCT 2024 Annual Meeting
Webinars
Webinar – Exploring Allogeneic Cell Therapies: Pioneering Advantages and Recent Innovations
Webinar – Harnessing STING & TLR: Current Developments, Clinical Trials, and Key Players in the Landscape
Webinar – Inflammatory Bowel Disease: A Comprehensive Analysis of Drug and Market Trends
ADC
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
ASCO 2024: ADC Highlights
Webinar – Exploring the Synergy of ADCs in Combination with Checkpoints: A Comprehensive Review
Bispecific
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
ASCO 2024: Bispecific Highlights
The 2023 Bispecific Landscape Review
Cancer Vaccine
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
Beacon Cancer Vaccine: 2024 ASCO Annual Meeting Abstracts
2023 Cancer Vaccine Landscape Review
Cell Therapy
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
Webinar – Exploring Allogeneic Cell Therapies: Pioneering Advantages and Recent Innovations
Unlock the Future of Advanced Therapies: Insights from the ASGCT 2024 Annual Meeting
Checkpoint
ASCO 2024: Checkpoint Highlights
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
Webinar – Harnessing STING & TLR: Current Developments, Clinical Trials, and Key Players in the Landscape
Cytokine
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
ASCO 2024: Cytokine Highlights
Charting the Course: Trends and Challenges in Early-Stage Cytokine-Based Drug Development Commercialization
DDR
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
Beacon DDR: ASCO Post-Conference Report 2024
Beacon DDR: AACR Post-Conference Report 2024
Gene Therapy
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
Unlock the Future of Advanced Therapies: Insights from the ASGCT 2024 Annual Meeting
Beacon Gene Therapy: 2024 ASGCT Annual Meeting Abstracts
Immune Tolerance
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
Beacon Immune Tolerance: 2024 EULAR Annual Meeting Abstracts
Webinar – Inflammatory Bowel Disease: A Comprehensive Analysis of Drug and Market Trends
Microbiome
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
Microbiome: US Market and LBP Development
Microbiome: Drug Development in Asia Infographic
Oncolytic Viruses
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
Beacon Oncolytic Viruses: 2024 ASCO Annual Meeting Abstracts
2023 Oncolytic Viruses Landscape Review
RNA
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
Unlock the Future of Advanced Therapies: Insights from the ASGCT 2024 Annual Meeting
Beacon RNA: AACR Post-Conference Report 2024
TPD
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
Beacon TPD: ASCO Post-Conference Report 2024
TPD: AACR Post-Conference Report 2024
About Beacon
See how our clinical trials and drug database solutions in action
We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.
